s of the presentations in these sessions are available at: http://www.isbgmo.info/assets_/isbgmo_ symposium_handbook.pdf Session 1: Biosafety – experience and results

Nanotechnology promises to improve the quality of human life, but it has also provoked concerns about potential adverse health effects on workers, the environment and consumers. Effective risk assessment and risk management of nanotechnology requires: 1) knowing how engineered nanoscale particles (NPs) can gain entry into the human body (routes of exposure); 2) knowing whether engineered NPs ca...

An expansion of today’s static definition biosafety to include research for mitigating risk will advance both science and public safety.